Back
Sands China Vs. Kymera Therapeutics Industry Stock Comparison
Sell
31
SCHYY
Sands China
Last Price:
19.02
Seasonality Move:
-1.69%
Buy
75
KYMR
Kymera Therapeutics
Last Price:
45.91
Seasonality Move:
1.07%
Sell
31
Sands China (SCHYY)
is a Sell
Is Sands China a Buy, Sell or Hold?
- The current Sands China [SCHYY] share price is $18.96. The Score for SCHYY is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- SCHYY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $48.55. The Score for KYMR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SCHYY Stock Price Chart
What is Sands China's stock price today?
-
The Sands China share price today is $18.96
The current trend is relatively stagnant and SCHYY is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $48.55
The current trend is moderately bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
SCHYY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.43 | Sell |
| Relative Strength Index (14 RSI): | 47.82 | Sell |
| Chaikin Money Flow: | 17881 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.06 - 19.58) | Buy |
| Bollinger Bands (100): | (19.68 - 26.12) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.63 | Buy |
| Relative Strength Index (14 RSI): | 66.81 | Buy |
| Chaikin Money Flow: | 401492 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.48 - 45.24) | Buy |
| Bollinger Bands (100): | (32.33 - 41.99) | Buy |
SCHYY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.49 | Buy |
| 20-day SMA: | 18.55 | Buy |
| 50-day SMA: | 20.2 | Sell |
| 200-day SMA: | 25.36 | Sell |
| 8-day EMA: | 18.7 | Buy |
| 20-day EMA: | 18.86 | Buy |
| 50-day EMA: | 20.25 | Sell |
| 200-day EMA: | 24.75 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.43 | Buy |
| 20-day SMA: | 43.41 | Buy |
| 50-day SMA: | 39.02 | Buy |
| 200-day SMA: | 33.59 | Buy |
| 8-day EMA: | 45.02 | Buy |
| 20-day EMA: | 43.36 | Buy |
| 50-day EMA: | 40.58 | Buy |
| 200-day EMA: | 34.57 | Buy |
Sands China Earnings Growth & SCHYY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.38 per share.
Sands China Technical Analysis
| Aug 8 | Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | Aug 19 | Aug 20 | Aug 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Aug 8 | Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | Aug 19 | Aug 20 | Aug 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||